Arjun Menon BE, Biomedical Engineering

Stryker Australia Receives TGA Approval for Total Temporomandibular Joint Prosthesis

Stryker Australia gains TGA approval for total temporomandibular joint prosthesis, expanding treatment options for TMJ disorders in Australia.

Australia's TGA Section 41HD Emergency Medical Device Import Approvals: Complete Guide for Healthcare Providers

Australia's TGA Section 41HD approvals enable emergency medical device imports during supply shortages. Learn eligibility criteria and application process.

Telix Pharmaceuticals' TLX250-Px Shows Promise for Diagnosing Multiple Kidney Cancer Types Beyond Clear Cell RCC

New Phase 3 ZIRCON analysis reveals TLX250-Px (Zircaix®) potential for diagnosing various kidney cancers, expanding beyond clear cell renal cell carcinoma applications.

Novo Nordisk Launches Wegovy in China Before Eli Lilly, Capturing World's Largest Obesity Market

Novo Nordisk secures first-mover advantage launching Wegovy in China ahead of Eli Lilly's competing obesity drug, targeting massive untapped market opportunity.

ROIS Expands to US Market as Global CDMO with FDA Approval for Injectable Drug Manufacturing

ROIS establishes US operations as global CDMO with FDA, EMA, and other major regulatory approvals for end-to-end injectable drug manufacturing services.

Inflation Reduction Act Pharmaceutical Impact: What You Need to Know

Learn about the Inflation Reduction Act's effects on pharmaceutical pricing, focusing on key medications like insulin and cancer therapies for Medicare patients.

African Medicines Agency impact: Harmonizing Clinical Trials in Africa

The African Medicines Agency is transforming clinical trials in Africa, streamlining processes for drug approvals and improving access to essential medicines.

Kodiak Sciences KSI-101 Clinical Data to Be Presented at Scientific Conferences for Macular Edema Treatment

Kodiak Sciences will present KSI-101 clinical data for macular edema secondary to inflammation, with Phase 3 results expected in Q4 2026.

ANVISA Approves MagicTouch SCB: What You Need to Know

ANVISA has officially approved MagicTouch SCB, a groundbreaking treatment for chronic pain, offering new hope for patients seeking relief.

Soleno Therapeutics Faces Securities Fraud Lawsuit Over Alleged Sham Phase 3 Clinical Trials

Soleno Therapeutics hit with securities fraud allegations claiming company conducted fraudulent Phase 3 trials that led to FDA drug approval.

TrialClinIQ Secures $150K Investment from Caduceus Capital to Transform Clinical Trial Recruitment with AI Technology

Houston-based TrialClinIQ raises $150K pre-seed funding and joins LAUNCH accelerator while opening $1.5M round to improve clinical trial access through AI.

Claruvis Pharmaceutical's Retoxin Becomes World's First Approved Recombinant Botulinum Toxin Type A in China

China's NMPA approves Retoxin, the world's first recombinant botulinum toxin type A, marking a technological breakthrough in aesthetic medicine treatments.

PSG 2026 Specialty Drug Benefits Report: Cost Management Remains Top Priority as Coverage Strategies Challenge Payers

PSG's 13th annual report reveals payers prioritize cost management while struggling with coverage strategies for new specialty drugs and indications.

PMC Organometallix Announces 10-25% Price Increases Across All Product Lines Effective May 2026

PMC Organometallix will implement 10-25% price increases on all products globally starting May 1, 2026, citing significant market condition changes.

Quasar Medical Opens New Thailand Manufacturing Facility to Expand MedTech Production Capacity

Quasar Medical inaugurates new Chonburi manufacturing facility in Thailand, boosting global production capacity for interventional medical devices.

NOVI Health's Hybrid Care Model Bridges GLP-1 Drug Efficacy Gap Between Clinical Trials and Real-World Outcomes

NOVI Health introduces hybrid care approach to improve real-world GLP-1 obesity drug outcomes that typically underperform compared to clinical trials.